PassPort Tech Announces Positive Results of Zolmitriptan for the Treatment of AM
29 Mar 2024 //
PR NEWSWIRE
PassPort Initiated Ph I Trial of Zolmitriptan Transdermal Microporation System
23 Feb 2024 //
PR NEWSWIRE
29 Mar 2024 //
PR NEWSWIRE
23 Feb 2024 //
PR NEWSWIRE